Juniper Investment Company, founded in 2007 by Alexis Michas and John Bartholdson, is an investment manager headquartered in New York City. The firm specializes in managing capital for the general partner, high-net-worth individuals, family offices, and institutional investors.
Mr. Alexis P. Michas co-founded Juniper and has served as its Managing Partner since its inception, bringing over 30 years of expertise in investment management and organizational leadership. He has been instrumental in overseeing significant ownership and controlling equity investments across diverse industries, with a robust portfolio spanning private and public companies. Mr. Michas' transactional prowess encompasses mergers and acquisitions, IPOs, debt and equity offerings, bank financings, recapitalizations, spin-offs, and going-private transactions. Currently, he chairs the boards of directors at BorgWarner Inc. and PerkinElmer Inc., and serves as a director at AstroNova, Inc. and Theragenics Corporation. His board experience extends to other notable companies, including AirTran Airways, Allied Motion Technologies Inc., Blue Bird Corporation, Burns International, Eckerd Corporation, Lincoln Educational Services Corp., and Packard BioScience Company. Mr. Michas also holds a directorship at a family of funds managed by Atlantic Investment Management, Inc. Previously, Mr. Michas served as Managing Partner at Stonington Partners, Inc. from 1994 to 2011 and held a managing partner role at Merrill Lynch Capital Partners, where he worked from 1984 to 1994. His career began in the investment banking division of Merrill Lynch. Mr. Michas earned his B.A. from Harvard College and his M.B.A. from Harvard Business School.
Mr. John A. Bartholdson co-founded Juniper and has been a Partner since its inception, bringing 25 years of experience in leading and overseeing private and public equity investments. His extensive background includes strategic management oversight, board service for multiple public and private companies, and profound transactional expertise, collaborating closely with Mr. Michas throughout their investment careers. Currently, Mr. Bartholdson serves as Chairman of the board of directors at Theragenics Corporation and holds board memberships at Bioventus Inc. and Lincoln Educational Services Corporation. Previously, he was a board member at Obagi Medical Products, Inc. until its acquisition by Valeant Pharmaceuticals. Mr. Bartholdson has also held director roles at numerous private companies. Before co-founding Juniper, Mr. Bartholdson served as a Partner at Stonington Partners from 1997 to 2011 and gained initial experience as an analyst at Merrill Lynch Capital Partners from 1992 to 1994. He earned his B.A. from Duke University and his M.B.A. from Stanford Graduate School of Business.
Juniper Investment Company is a hedge fund managing discretionary assets totaling $288,276,247 for 6 clients (per Form ADV dated 2024-03-29). In their latest Q1 2024 13F filing, the firm reported $200,968,274 in managed 13F securities, with a top 10 holdings concentration of 100.0%. Their largest holding is Artivion Inc., with 2,098,164 shares held.